HKAPI RSA Workshop 2026

Dear Members,

Further to the CEO Meeting announcing the RSA pilot between the industry and HA, we are pleased to invite you to join a follow-up workshop to support members’ preparation for potential RSA/MEA pilot submissions.

Workshop: Preparing for RSA Pilots with the Hospital Authority: From International Experience to Practical Proposals
Date & Time: 20 November 2026, 2:30 pm – 5:00 pm
Format: Face-to-Face only
Venue: Please contact the HKAPI Office for details
Speaker: Dr. Indranil Bagchi, Global Head of Pricing & Market Access, GSK

We are delighted to have Dr. Indranil Bagchi join us to share international experience on risk-sharing arrangements and managed-entry agreements. Dr. Bagchi will discuss how RSAs and MEAs can help manage uncertainty in efficacy, cost-effectiveness, budget impact, and long-term outcomes, and share relevant international examples and lessons for Hong Kong.

The workshop will also include a co-creation session to develop a draft template for submission to CPO, covering proposed RSA/MEA models, supporting evidence, data requirements, implementation considerations, and measures of success. Members will have the opportunity to exchange views and contribute to practical next steps for the RSA pilot.

The workshop will be particularly relevant to colleagues involved in HA engagement, drug listing, evidence generation, pricing, and pilot preparation.

During registration, please kindly provide your job title. This information will help us organize the group discussions in Session 2 and ensure a balanced mix of perspectives.

Please register by contacting Ms Catherine Chau of the HKAPI Office.